This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026
Hynes Convention CenterBoston, USA
Register For Passes Today
Menu
Book Now
Key Sessions
Fouad Atouf
PLENARY KEYNOTE: Evolving Pharmacopeial Standards to Shape the Future of Biological Medicines
US Pharmacopeia
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL
keyboard_arrow_right

Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
11:25am - 11:30am
Chairperson Remarks: Manufacturing Strategy & Digitalization
  • Shanta Boddapati, PhD - Associate Director, Upstream PD, Immunome, Inc
11:30am - 12:00pm
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
  • Kelvin Lee - Institute Director, NIIMBL
12:00pm - 12:30pm
AI-Enhanced Smart Workflows: Unlocking Speed and Insight in Process Development and Manufacturing
  • Mark Duerkop - Chief Executive Officer, Novasign, Austria
12:30pm - 1:00pm
Building a robust compliance infrastructure to meet pre-use, post-sterilization integrity testing (PUPSIT) requirements
  • Ross Turmell - Principal Scientist, Cytiva
Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson Remarks: Manufacturing Strategy & Digitalization
  • James Kranz - VP and Head of CMC, Compass Therapeutics
2:15pm - 2:45pm
CMC in the Age of Personalized Medicine: Meeting the Unique Challenges of Small Batch Manufacturing
  • Gregory Zarbis-Papastoitsis, Ph.D - Chief Process and Manufacturing Officer, Ankyra
2:45pm - 3:15pm
CMC Regulatory Filings for NCE’s – How to Develop Module 3 for the FDA and the EU/UK without constraining Development Efforts
  • Jack Greene - Chief Technical and Manufacturing Officer, JucaBio
3:15pm - 3:45pm
Enhancing Yield and Purity in Nanobody-Fc Fusion Protein Purification: The Role of Novel Alkaline-Stable rProtein A Development through C Domain Structure Shuffling
  • Simona Serban - Director, Global Life Sciences Applications, Sunresin New Materials
Showing 1 of 1 Streams
4:30pm - 5:00pm
Creating a Winning Target Product Profile: A Roadmap for Successful Biopharmaceutical Development
  • Regina Au - CEO, New Product Planning/Strategic Planning, BioMarketing Insight
5:00pm - 5:30pm
Overcoming Challenges in an ADC Process Performance Qualification Campaign
  • Siu-Man (Kelvin) Lau - Principal Engineer, Abbvie
Tuesday 16th September - Main Conference Day One
NextThursday 18th September - Main Conference Day Three
Filter
Streams
Clear
Choose Day